Hepatoblastoma is the most common pediatric liver malignancy and usually occurs within the first 3 years of life. In recent years, the overall incidence of hepatoblastoma has exhibited the greatest increase among all pediatric malignancies worldwide. The diagnosis of hepatoblastoma may be challenging due to the lack of a current consensus classification system. The International Pediatric Liver Tumors Consensus introduced guidelines and a consensus classification for the diagnosis of hepatoblastoma as either epithelial or mixed epithelial and mesenchymal and in the updated 5th edition of the World Health Organization Classification of Digestive System Tumors.
Citations
Citations to this article as recorded by
Tumor‐associated macrophages: The key player in hepatoblastoma microenvironment and the promising therapeutic target Ahmad Adawy, Yoshihiro Komohara, Taizo Hibi Microbiology and Immunology.2024; 68(8): 249. CrossRef
Hepatoblastoma: A Case Report Abel Ning Caballero, Kandecy Archer-Austin Asploro Journal of Biomedical and Clinical Case Reports.2024; 7(3): 226. CrossRef
Adult Hepatoblastoma and Concomitant Hepatitis B Infection Alejandro Nieto Dominguez, Sarah Elizabeth Eichinger, Elza Matrova, Anas Almoghrabi ACG Case Reports Journal.2024; 11(9): e01491. CrossRef
Metabolic and Epigenetic Mechanisms in Hepatoblastoma: Insights into Tumor Biology and Therapeutic Targets Yuanji Fu, Raquel Francés, Claudia Monge, Christophe Desterke, Agnès Marchio, Pascal Pineau, Yunhua Chang-Marchand, Jorge Mata-Garrido Genes.2024; 15(11): 1358. CrossRef
Adult hepatoblastoma: making the challenging distinction from hepatocellular carcinoma Allison Kaye L. Pagarigan, Paulo Giovanni L. Mendoza Journal of Liver Cancer.2023; 23(1): 219. CrossRef
Advances in Histological and Molecular Classification of Hepatocellular Carcinoma Joon Hyuk Choi, Swan N. Thung Biomedicines.2023; 11(9): 2582. CrossRef